| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 31-Mar-09 | 28-Dec-08 | | Total Revenue | 367,325 | 340,265 | 393,167 | 460,878 | | Cost of Revenue | 278,708 | 262,804 | 302,845 | 359,342 | | | Gross Profit | 88,617 | 77,461 | 90,322 | 101,536 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 60,284 | 54,408 | 56,170 | 66,324 | | Non Recurring | 3,184 | 3,519 | 22,565 | (3,708) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 25,149 | 19,534 | 11,587 | 38,920 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (824) | (1,882) | (879) | 13,038 | | Earnings Before Interest And Taxes | 24,325 | 17,652 | 10,708 | 51,958 | | Interest Expense | 5,622 | 5,378 | 5,088 | 5,606 | | Income Before Tax | 18,703 | 12,274 | 5,620 | 46,352 | | Income Tax Expense | 5,798 | 3,863 | 2,311 | 15,761 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 12,905 | 8,411 | 3,309 | 30,591 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 12,905 | 8,411 | 3,309 | 30,591 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $12,905 | $8,411 | $3,309 | $30,591 |
|
0.51% Nasdaq 
Income Statement
